械

Search documents
采矿业对电动铲运设备:需求总量上升、技术要求提高
工程机械杂志· 2025-07-21 11:55
新能源矿产开发需求突出 新能源产业的快速发展,使得锂、钴等新能源矿产的开采需求大增,成为电动铲运设备需求的新增长点。新能 源矿产开发对电动铲运设备的需求占比已从 2020 年的 12% 提升至2023 年的 18%,预计到 2030 年将突破 30%。 地下开采需求增长明显 深部矿产资源开发需求持续释放,推动了地下电动铲运设备需求的增长。地下铲运机在整体市场中的占比由 2018 年的 32% 提升至 2022 年的 41%,如徐工地下电动铲运机就凭借紧凑机身和高效性能,在辽宁铜锌矿等 地下矿山开采中发挥了重要作用。 在 "双碳" 目标背景下,采矿业对电动铲运设备的需求正逐渐增加,呈现出需求总量上升、技术要求提高等特 点。 需求总量持续增长 随着全球矿产资源的持续开发,以及 "双碳" 目标驱动,采矿业对电动铲运设备的需求不断上升。2023 年中国 铲运机市场规模约为 120 亿元人民币,预计 2025 年将突破 150 亿元,年均复合增长率保持在 8% 左右,其中 电动铲运机在 2023 年的渗透率约为 15%,预计 2025 年将提升至30%,2030 年有望超过 50%。 环保要求推动需求提升 环保意识的增 ...
【21日资金路线图】有色金属板块净流入近70亿元居首 龙虎榜机构抢筹多股
证券时报· 2025-07-21 11:47
7月21日,A股市场整体上涨。 截至收盘,上证指数收报3559.79点,上涨0.72%,深证成指收报11007.49点,上涨0.86%,创业板指收 报2296.88点,上涨0.87%,北证50指数上涨2.38%。A股市场合计成交17274.28亿元,较上一交易日增 加1339.22亿元。 1. A股市场全天主力资金净流出136.41亿元 今日A股市场主力资金开盘净流出52.22亿元,尾盘净流入15.76亿元,全天净流出136.41亿元。 | | | 沪深两市近五日主力资金流向情况(亿元) | | | | --- | --- | --- | --- | --- | | 日期 | | 净流入金额 开盘净流入 | | 尾盘净流入 超大单净买入 | | 2025-7-21 | -136.41 | -52. 22 | 15. 76 | -9.08 | | 2025-7-18 | -256. 41 | -65. 68 | -5.90 | -135.30 | | 2025-7-17 | 69.86 | -16. 82 | 13. 64 | 124. 01 | | 2025-7-16 | -134. 35 | -8.00 | ...
爆了!祖训也有不灵的时候
Datayes· 2025-07-21 11:16
A股复盘 |一大堆段子来袭 / 2025.07.21 鉴于之前周末热议的题材周一一般都套人,加上晚上看到网上说有人24年就埋伏了! 心想,不好,雅江水电站这不会要高开低走吧! 哎,祖训这次失灵了,哈哈哈,今天带动了一整个基建产业链! 股民们积极学习如何建设水电站,从爆破,到电网设备,从挖掘机等工程机械,到钢筋水泥等建材! 刚刚又学了一个 盾构机 , 雅鲁藏布江下游水电工程需在喜马拉雅山系打通45公里引水隧道,最大埋深超两千米,岩体破碎、涌水突泥频发,传统钻爆法风 险高、进度慢。采用直径15米级盾构机,月进尺120—150米,较钻爆法提升50%,并配备自动换刀、超前地质预报系统,可在高应力、大变形地层中连续 作业。 这强大的国运线都把债市干趴了! 哈哈哈,彭博援引的业内人士分析,这提升了市场对更多刺激措施将推出的预期。 政治局会议马上来了,又开始炒预期了! | 机构 | 货币政策 | 财政改策 | 产业政策 | 楼市 | 股市 *十五五*规划 要求研究中长期经济社会发展的战略性 | | | --- | --- | --- | --- | --- | --- | --- | | | 下半年可能再次降准降息,改策偏 ...
晚间公告丨7月21日这些公告有看头
Di Yi Cai Jing· 2025-07-21 10:47
Group 1 - Jiangte Electric plans to change its control rights, with stock suspension starting from July 22, expected to last no more than 2 trading days. Additionally, its subsidiary Yichun Yinli will suspend operations for equipment maintenance for approximately 26 days, which is not expected to significantly impact annual performance [3] - Core Technology intends to sell 100% equity of its subsidiary Zhongshan Core Automation Technology for 156 million yuan and transfer related assets for a total of approximately 82 million yuan. The company aims to optimize its business structure by consolidating resources [4] - Fengmao Co. plans to invest no more than 1.5 billion yuan to establish an intelligent chassis thermal control system production base in Yuyao, while terminating the project for a parts production base in Jiaxing, which had not yet commenced [5] - Haopeng Technology's controlling shareholder voluntarily extends the lock-up period for pre-IPO restricted shares by 12 months, reflecting confidence in the company's future development [6] - Good Products has been involved in a share transfer dispute, with the court accepting the case involving 996 million yuan. The outcome may introduce uncertainties regarding the control transfer of its major shareholder [7] Group 2 - Haitan Ruisheng expects a net profit increase of 607.01% to 960.52% for the first half of 2025, driven by rapid growth in AI technology and its applications [9] - GeKao Micro anticipates a revenue growth of 22.27% to 36.51% for the first half of 2025, supported by the recognition of its high-pixel chip integration technology [10] - Jinghe Integration forecasts a net profit increase of 39.04% to 108.55% for the first half of 2025, benefiting from improved industry conditions and increased product sales [11] - Best Beauty expects a net profit increase of 100.07% to 168.38% for the first half of 2025, attributed to significant profit growth in trade products [12] - Juzan Optoelectronics reports a net profit growth of 3.43% for the first half of 2025, with a proposed stock dividend of 4.5 shares for every 10 shares held [13] - Changshu Bank reports a net profit of 1.969 billion yuan for the first half of 2025, a year-on-year increase of 13.55% [14] - Keda Li anticipates a net profit increase of 15.73% to 26.53% for the first half of 2025, driven by the growth in new energy vehicle sales [15] - *ST Sitong reports a net loss of 16.201 million yuan for the first half of 2025, despite a revenue increase of 75.88% [16] Group 3 - Gaode Infrared has signed contracts totaling 685 million yuan for overseas market orders, representing 25.59% of its projected 2024 revenue [18] - Dajin Heavy Industry has signed a contract worth approximately 430 million yuan for offshore wind farm foundation supplies, accounting for 11.38% of its projected 2024 revenue [20] - Dongfang Precision has established a strategic partnership with Leju Robotics, focusing on embodied intelligent robots [21] - Chuling Information's subsidiary has signed a framework contract with China Mobile for a total amount of 421 million yuan, involving intelligent network integration products [22] - Hongxin Technology has entered into contracts with a leading domestic flying car company for component development and procurement [23] Group 4 - Dongcai Technology's chairman plans to reduce his stake by up to 0.43% due to personal financial needs [25] - Tianchuang Fashion's shareholder Visions plans to reduce its stake by up to 1% through centralized bidding [26]
工程机械行业点评报告:雅鲁藏布江大项目正式开工,工程机械行业迎重大机遇
Soochow Securities· 2025-07-21 10:35
增持(维持) 工程机械行业点评报告 雅鲁藏布江大项目正式开工,工程机械行业 迎重大机遇 [投资要点 Table_Summary] ◼ 雅鲁藏布江下游水电工程开工,工程机械行业迎重大机遇 7 月 19 日,李强宣布雅鲁藏布江下游水电项目开工,工程建设正 式拉开帷幕;同时,国务院国资委宣布中国雅江集团有限公司正式成 立,成为国务院国资委监管的第 99 家央企。雅江下游水电项目位于西 藏自治区林芝市,工程主要采取截弯取直、隧洞引水的开发方式,建设 5 座梯级电站,总投资约 1.2 万亿元(三峡工程静态投资 1353 亿元,为 雅江项目九分之一),总装机容量规划预计达 60GW(三峡水电站 22.5GW),预计年发电量 3000 亿千瓦时(约为三峡三倍)。根据我们测 算,该项目土方量超 5 亿立方,工程机械需求涵盖大型挖掘机、装载 机、矿卡、混凝土机械、路面机械等,有望大幅拉动国内工程机械需求。 证券研究报告·行业点评报告·工程机械 ◼ 高原带来电动化&无人化机会,工程机械利润弹性大 按三峡水电站的项目投资来看,土建占比约占 60%,其中工程机械 设备类如挖掘机、装载机、矿车、掘进盾构等产品占比约 15%-20%。 ...
突然,暴涨700%!买盘为何如此“凶悍”?
券商中国· 2025-07-21 10:20
难得一见的乌龙指! 港股市场东方电气今日刷屏,该股最高涨至119.9港元/股,较前一个交易日收盘价上涨超700%。分析人士认 为,这可能是一笔乌龙指,交易员原本或许想以19.9港元/股买入,却误输入为119.9港元/股。不过,这笔单子 并不大。 然而,若这只是一笔乌龙指,其意义却可能并不仅限于其本身,更多的在于市场的情绪。一般情况下,买盘如 此急促,显示了多头对于当下市场的认可。因为,在这一笔乌龙之前,东方电气的成交价格为19.32港元/股, 若交易员敲出一笔19.9港元/股的价格,亦比19.32港元/股高出3%。 那么,这个利好究竟会有多大?持续性又如何? 暴涨700% 7月21日早上,东方电气突然异动,该股H股在开盘后不久,出现一笔以119.9港元/股的价格成交,较上一笔交 易19.32港元/股暴涨520%,较上一日收盘更是暴涨超700%。随后,该股股价快速回落,目前涨幅在60%上 下。 有分析指出,该笔交易可能是一个乌龙指,即交易员原本或许想以19.9港元/股买入,却误输入为119.9港元/ 股。然而,即使考虑到乌龙指,也显示出投资者在买入该股时"志在必得"的心态,因为在这一笔乌龙之前,东 方电气的成交 ...
1.2万亿超级工程启动,如何借助ETF“喝口汤”?
市值风云· 2025-07-21 10:09
当年三峡工程、后来雄安新区都跑出一批超级牛股。 | 作者 | | 紫枫 | | --- | --- | --- | | 编辑 | | 小白 | 周末,A股注册制时代投资者必须使用的APP——市值风云App的社区被雅鲁藏布江水电工程刷屏 了。 1.2万亿的投资额,引爆了全国舆论。 超级工程的基本情况和概念股 雅鲁藏布江下游水电工程,即墨脱水电站,是中国近年来备受瞩目的国家级重点工程之一。 该工程位于西藏自治区林芝市,采用"截弯取直+隧洞引水"的创新开发方式,计划建设5座梯级电站, 总投资额高达1.2万亿元,规划装机容量接近7000万千瓦,年发电量预计超过3000亿千瓦时。 这些数字不仅体现了工程的规模之大,更凸显了其在中国能源战略中的重要地位。 早在2021年3月《中华人民共和国国民经济和社会发展第十四个五年规划和 2035 年远景目标纲要》中 就曾明确了十四五期间"实施雅鲁藏布江下游水电开发"。 2024年12月25日,中国政府正式核准该工程,标志着其从规划阶段进入实施阶段。 2025年3月,国家发改委将其列为年度重点领域重大投资项目,并推动开工。 2025年4月,为推进工程,专门成立了新的央企——中国雅江集 ...
最新!福瑞股份2025年半年度业绩预告
思宇MedTech· 2025-07-21 10:03
Core Viewpoint - The company, Furui Co., Ltd. (stock code: 300049), is forecasting a significant decline in net profit for the first half of 2025 compared to the same period in 2024, with expected profits ranging from 50 million to 60 million yuan, representing a year-on-year decrease of 20% to 34% [2]. Group 1: Financial Performance - The net profit attributable to shareholders is projected to be between 50 million and 60 million yuan, down from 75.36 million yuan in the same period last year, indicating a decline of 20% to 34% [2]. - The net profit after deducting non-recurring gains and losses is expected to be between 51.5 million and 61.5 million yuan, compared to 74.46 million yuan in the previous year, reflecting a decrease of 17% to 31% [2]. - The company anticipates a net profit of approximately 75 million to 85 million yuan after excluding the impact of stock incentive expenses and exchange losses, which would represent a year-on-year growth of about 5% to 19% [7]. Group 2: Business Overview - Furui Co., Ltd. specializes in the research, development, production, and sales of medical devices and treatments for liver diseases, with a focus on the compound tortoise shell soft liver tablet, the first anti-liver fibrosis drug approved by the National Medical Products Administration [4][5]. - The company reported a revenue of 283 million yuan from its proprietary drug business in 2024, marking a year-on-year increase of 44.31% [5]. - The medical device segment has shown growth, with sales revenue expected to be between 470 million and 490 million yuan, reflecting an increase of approximately 11% to 16% compared to the previous year [7]. Group 3: Development and Services - The company has developed and sells the FibroScan series of liver fibrosis diagnostic instruments and the FibroMeter series of blood testing analysis tools, which are recognized for their innovative non-invasive detection technology [8]. - Furui Co., Ltd. provides chronic disease management services for liver disease patients through its internet hospital, establishing a comprehensive and personalized healthcare management platform [8]. - The company is also involved in software development, IT consulting services, and real estate operations, diversifying its business portfolio [8].
进入创新通道!牙种植牵引器
思宇MedTech· 2025-07-21 10:03
招商通知: 2025年9月4-5日,第三届全球手术机器人大会 2025年7月2日,NMPA公布了创新医疗器械特别审查申请审查结果公示(2025年第6号),有 14款产品 进入创新通道。其中包括, 上海央山生物科技有限公司 申请的 牙种植牵引器 。 许多患者在种植牙手术前存在 牙槽骨萎缩或骨量不足 的问题,这增加了手术的难度和风险。传统的骨增量方法如骨移植和引导骨再生(GBR)虽然有效,但存在 手术复杂、创伤大、恢复时间长等缺点。 牵引成骨技术 作为一种新兴的骨增量方法,具有 无需供体区、不增加周围软组织的同期延长等优点 。该技术通过施加适当的牵引力,促进牙槽骨冠方的新骨形 成,从而为种植牙手术提供更好的骨条件。 随着数字化技术在口腔医学中的应用,如 3D打印、计算机辅助设计与制造(CAD/CAM) 等,牙种植手术的精准性和可预测性得到了显著提高。牙种植牵引器的 研发正是顺应了这一趋势,通过精准的牵引力控制和数字化设计,进一步提升了种植牙手术的成功率。 牵引成骨技术在口腔种植领域的应用已经取得了一定的临床 效果。研究表明, 通过水平牵引成骨术可以增加牙槽骨的骨量 ,为种植体的植入提供更好的条件。此 外, 牵引成 ...
799亿!雅培发布最新财报
思宇MedTech· 2025-07-21 10:03
招商通知: 2025年9月4-5日,第三届全球手术机器人大会 2025年7月17日, 雅培公司(Abbott, NYSE: ABT) 公布了截至6月30日的2025年第二季度财务业绩。季度营收达111.42亿美元(约合人民币 799亿 ),同比增长 7.4%;有机增长(不计汇率及结构调整)达6.9%,高于市场预期。公司继续受益于核心产品线的稳健表现,特别是在医疗器械与营养品领域。 雅培董事长兼首席执行官Robert B. Ford表示:"我们再次交出了一份强劲的成绩单,多个业务实现两位数增长。我们对全年业绩增长充满信心,并继续加大在创新产品 和高增长市场的投入。" # 财 报 亮 点 : 多 项 核 心指 标 稳 中 向 好 | | | | | Established | | | --- | --- | --- | --- | --- | --- | | Sales 2Q25 ($ in millions) | Total Company | Nutrition | Diagnostics | Pharmaceuticals | Medical Devices | | U.S. | 4,276 | 957 | ...